A measure approved by the Oregon House seeks to remove financial barriers that can stand between patients and potentially lifesaving cervical cancer care, requiring insurers to fully cover not only screenings but also medically necessary follow-up examinations.
The legislation, Senate Bill 1527, prohibits deductibles, copayments, and other out-of-pocket costs for cervical cancer screenings and subsequent diagnostic procedures when abnormalities are detected. The policy applies to private insurance plans as well as coverage provided through the Public Employees’ Benefit Board and the Oregon Educators Benefit Board.
Supporters describe the change as a correction to a gap that has existed in health coverage for years. While many insurance plans have covered routine Pap tests and other screening tools, patients who receive abnormal results can face unexpected charges for additional diagnostic procedures. Those costs, particularly for individuals with high-deductible health plans, have led some to delay or forgo follow-up care.
Cervical cancer is widely considered one of the most preventable forms of cancer when detected early. Routine screenings are designed to identify precancerous changes before they develop into invasive disease. However, public health officials note that the effectiveness of screening depends on patients completing the full diagnostic process when irregularities are found.
Representative Annessa Hartman of Gladstone and Oregon City, who disclosed her Stage 3 cervical cancer diagnosis last year, testified in favor of the measure. In public remarks, she emphasized that prevention requires more than an initial test and warned that screening without affordable follow-up can create what she described as a false sense of security.
Data presented during legislative consideration showed that just over half of women between the ages of 25 and 44 are up to date on cervical cancer screenings. That figure, 53.1 percent, does not account for individuals who begin the screening process but encounter financial barriers before completing recommended diagnostic care.
Health policy advocates argue that cost-sharing requirements can disproportionately affect lower-income patients and those enrolled in high-deductible plans. Even relatively modest copayments can become obstacles when additional procedures such as colposcopies or biopsies are required after an abnormal screening result.
Senator Deb Patterson of Salem, a chief sponsor of the bill, stated during floor debate that patients have missed opportunities for early intervention when treatment is most effective. Early-stage cervical cancer is often highly treatable, and in many cases curable, when identified promptly. Delays in follow-up care can allow disease progression, potentially leading to more complex treatment and poorer outcomes.
Under the new requirements, insurers operating in the state must treat cervical cancer screenings and the medically necessary follow-up examinations as preventive services without cost-sharing. The goal is to ensure that patients are not forced to pause or abandon care because of financial concerns.
Supporters also framed the policy as part of a broader public health effort to reduce cancer incidence through vaccination, routine screening, and early intervention. Medical experts have long pointed to the combination of human papillomavirus vaccination and consistent screening as key tools in lowering cervical cancer rates.
While the legislation does not directly address screening participation rates, backers contend that eliminating surprise medical bills could improve patient confidence in seeking care. For some individuals, the uncertainty surrounding potential out-of-pocket expenses has served as a deterrent.
The bill passed with bipartisan backing in both chambers and now awaits implementation. If enacted as scheduled, insurers will be required to adjust their coverage policies to comply with the new standards.
Public health officials continue to encourage regular screenings according to medical guidelines. With the financial barriers reduced, proponents believe more patients will be able to complete the full continuum of care, from the first screening appointment to any necessary diagnostic follow-up, without facing additional economic strain.